CASI Pharmaceuticals, Inc (DE) Quarterly Revenues in USD from Q1 2011 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
CASI Pharmaceuticals, Inc (DE) quarterly/annual Revenues history and growth rate from Q1 2011 to Q4 2022.
  • CASI Pharmaceuticals, Inc (DE) Revenues for the quarter ending December 31, 2022 was $15.3M, a 66.6% increase year-over-year.
  • CASI Pharmaceuticals, Inc (DE) Revenues for the twelve months ending December 31, 2022 was $43.1M, a 42.9% increase year-over-year.
  • CASI Pharmaceuticals, Inc (DE) annual Revenues for 2022 was $43.1M, a 42.9% increase from 2021.
  • CASI Pharmaceuticals, Inc (DE) annual Revenues for 2021 was $30.2M, a 99.2% increase from 2020.
  • CASI Pharmaceuticals, Inc (DE) annual Revenues for 2020 was $15.1M, a 267% increase from 2019.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $43.1M $15.3M +$6.1M +66.6% Oct 1, 2022 Dec 31, 2022 20-F 2023-04-26
Q3 2022 $37M $10.2M +$2.1M +25.9% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $34.9M $8.57M +$1.41M +19.7% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $33.5M $9.06M +$3.33M +58% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $30.2M $9.16M +$4.34M +89.9% Oct 1, 2021 Dec 31, 2021 20-F 2023-04-26
Q3 2021 $25.8M $8.11M +$3.87M +91.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $22M $7.16M +$4.49M +168% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $17.5M $5.74M +$2.33M +68.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $15.1M $4.82M +$3.48M +259% Oct 1, 2020 Dec 31, 2020 20-F 2023-04-26
Q3 2020 $11.7M $4.24M +$1.46M +52.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $10.2M $2.67M +$2.67M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $7.54M $3.41M +$3.41M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $4.13M $1.34M +$1.34M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 $2.79M $2.79M +$2.79M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $0 $0 $0 Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $0 $0 $0 Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $0 $0 Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 $0 $0 Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $0 $0 Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $0 Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q3 2017 $0 Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $0 Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q4 2012 $669K $669K -$1.26M -65.4% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-21
Q3 2012 $1.93M $0 $0 Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-14
Q2 2012 $1.93M $0 -$8.85K -100% Apr 1, 2012 Jun 30, 2012 10-Q 2012-08-14
Q1 2012 $1.94M $0 $0 Jan 1, 2012 Mar 31, 2012 10-Q 2012-05-15
Q4 2011 $1.94M $1.93M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-21
Q3 2011 $0 Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 $8.85K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 $0 Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.